COMMUNIQUÉS West-GlobeNewswire

Sanofi : Disclosure of trading in own shares

17/07/2017 - 18:00

Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Sanofi : Déclaration des transactions sur actions propres

17/07/2017 - 18:00

Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Diaxonhit : mise en oeuvre du regroupement d'actions par 20 entre le 1er août et le 1er septembre 2017

17/07/2017 - 17:45

MISE EN OEUVRE DU REGROUPEMENT D'ACTIONS DIAXONHIT Regroupement d'actions par voie d'échange à raison de 1 action nouvelle regroupée contre 20 actions anciennes ; Début des opérations de regroupement : 1 er août 2017 ; [...]

Virbac : la croissance du chiffre d'affaires au deuxième trimestre rattrape en grande partie le recul du premier trimestre

17/07/2017 - 17:45

Virbac : la croissance du chiffre d'affaires au deuxième trimestre rattrape en grande partie le recul du premier trimestre Communiqué diffusé le 17 juillet 2017 Le chiffre d'affaires du Groupe au deuxième trimestre s' [...]

Virbac: second quarter sales growth largely offsets the decline in the first quarter

17/07/2017 - 17:45

Virbac: second quarter sales growth largely offsets the decline in the first quarter Public release - July 17, 2017 Virbac consolidated revenue in the second quarter amounted to €234.8 million, up sharply by +7.5% [...]

Solon Eiendom ASA : Primary insider notification

17/07/2017 - 17:40

(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 25,000 shares in Solon Eiendom ASA at a price of NOK 19. Following this [...]

Solon Eiendom ASA : Primary insider notification

17/07/2017 - 17:37

(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 80,986 shares in Solon Eiendom ASA at a price of NOK 18,9888. Following [...]

Targovax ASA: Final result of the subsequent offering

17/07/2017 - 15:24

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Five-Year Data Demonstrate InterStim(TM) Therapy Offers Sustained Long-Term Efficacy and Quality of Life Improvements for Overactive Bladder Patients

17/07/2017 - 15:00

The InterStim System is the Only Proven, Long-Term Sacral Neuromodulation Solution for Overactive Active Bladder DUBLIN - July 17, 2017 - Medtronic plc (NYSE: MDT) today announced that the InterStim(TM) system, which [...]

RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D

17/07/2017 - 14:00

Top-line results are expected in September 2017 The randomized, double-blind, placebo-controlled Phase II study is evaluating the safety and efficacy of BEKINDA ® (RHB-102) 12 mg in 127 U.S. patients with diarrhea- [...]

Novo Nordisk A/S - Share repurchase programme

17/07/2017 - 13:56

Bagsværd, Denmark, 17 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

MITHRA SUBMITS MYRING(TM) FOR EUROPEAN MARKETING APPROVAL

17/07/2017 - 07:30

PRESS RELEASE mithra submits MYRING(TM) For EUROpean Marketing approval Myring(TM) regulatory approvals in Europe and the US expected in 2018 Regulatory s ubmission follows recent European GMP approval for Myring(TM) [...]

ABLYNX PROPOSES APPOINTMENT OF MRS HILDE WINDELS AS A NEW INDEPENDENT DIRECTOR

17/07/2017 - 07:00

GHENT, Belgium, 17 July 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that Hilde Windels will be nominated as an Independent Non-Executive Director at the Company's forthcoming Special General [...]

L'Association internationale pour l'étude du cancer du poumon annonce la 18e Conférence mondiale IASLC sur le cancer du poumon

14/07/2017 - 20:00

La seule conférence mondiale axée uniquement sur le cancer du poumon regroupera des milliers de personnes au Japon DENVER, le 14 juillet 2017 (GLOBE NEWSWIRE) - L'Association internationale pour l'étude du cancer du [...]

Novartis confirms 5 year data for first and only fully-human IL-17A inhibitor Cosentyx® reinforcing sustained efficacy and safety profile in psoriasis

14/07/2017 - 19:21

5 year data from long-term Phase III extension study demonstrate sustained efficacy and safety of Cosentyx in patients with moderate-to-severe plaque psoriasis[1] Data planned to be presented at a key medical congress [...]

IBA SA : IBA - NOTIFICATION DE TRANSPARENCE

14/07/2017 - 17:50

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 14 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

IBA SA : IBA - TRANSPARENCY NOTIFICATION

14/07/2017 - 17:50

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 14, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

Targovax ASA: Preliminary result of the subsequent offering

14/07/2017 - 17:24

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Crown Bioscience enrichit son portefeuille de sciences de la vie

14/07/2017 - 12:45

SANTA CLARA, Californie, le 14 juillet 2017 (GLOBE NEWSWIRE) - Crown Bioscience , filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services de [...]